These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 34657141)

  • 1. A positive feedback loop of lncRNA-RMRP/ZNRF3 axis and Wnt/β-catenin signaling regulates the progression and temozolomide resistance in glioma.
    Liu T; Hu J; Han B; Tan S; Jia W; Xin Y
    Cell Death Dis; 2021 Oct; 12(11):952. PubMed ID: 34657141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA‑301a/ZNRF3/wnt/β‑catenin signal regulatory crosstalk mediates glioma progression.
    Sun J; Ma Q; Shu C; Xiong J; Li B; Wu J; Zhang S; Li J; Liu J; Wang J
    Int J Oncol; 2021 Jan; 58(1):45-56. PubMed ID: 33367931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
    Li C; Feng S; Chen L
    Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LINC00511 facilitates Temozolomide resistance of glioblastoma cells via sponging miR-126-5p and activating Wnt/β-catenin signaling.
    Lu Y; Tian M; Liu J; Wang K
    J Biochem Mol Toxicol; 2021 Sep; 35(9):e22848. PubMed ID: 34328678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RPN2 is targeted by miR-181c and mediates glioma progression and temozolomide sensitivity via the wnt/β-catenin signaling pathway.
    Sun J; Ma Q; Li B; Wang C; Mo L; Zhang X; Tang F; Wang Q; Yan X; Yao X; Wu Q; Shu C; Xiong J; Fan W; Wang J
    Cell Death Dis; 2020 Oct; 11(10):890. PubMed ID: 33087705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mannose inhibits proliferation and promotes apoptosis to enhance sensitivity of glioma cells to temozolomide through Wnt/β-catenin signaling pathway.
    Fei YQ; Shi RT; Zhou YF; Wu JZ; Song Z
    Neurochem Int; 2022 Jul; 157():105348. PubMed ID: 35490896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol restores sensitivity of glioma cells to temozolamide through inhibiting the activation of Wnt signaling pathway.
    Yang HC; Wang JY; Bu XY; Yang B; Wang BQ; Hu S; Yan ZY; Gao YS; Han SY; Qu MQ
    J Cell Physiol; 2019 May; 234(5):6783-6800. PubMed ID: 30317578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UBE2T Promotes Temozolomide Resistance of Glioblastoma Through Regulating the Wnt/β-Catenin Signaling Pathway.
    Wang Y; Gao G; Wei X; Zhang Y; Yu J
    Drug Des Devel Ther; 2023; 17():1357-1369. PubMed ID: 37181827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circ
    Li J; Ma J; Huang S; Li J; Zhou L; Sun J; Chen L
    Mol Cell Biol; 2023; 43(7):354-369. PubMed ID: 37427890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms for hypoxia
    Zhao H; Meng L; Liao X; Liu Y; Mo X; Gong M; Liao Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 47(7):829-838. PubMed ID: 36039578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species.
    Bi Y; Li H; Yi D; Bai Y; Zhong S; Liu Q; Chen Y; Zhao G
    Cancer Lett; 2018 Oct; 435():66-79. PubMed ID: 30081068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temozolomide induces activation of Wnt/β-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy.
    Tomar VS; Patil V; Somasundaram K
    Cell Biol Toxicol; 2020 Jun; 36(3):273-278. PubMed ID: 31758290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis.
    Tang JH; Yang L; Chen JX; Li QR; Zhu LR; Xu QF; Huang GH; Zhang ZX; Xiang Y; Du L; Zhou Z; Lv SQ
    Cancer Commun (Lond); 2019 Dec; 39(1):81. PubMed ID: 31796105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oroxylin A reversed Fibronectin-induced glioma insensitivity to Temozolomide by suppressing IP
    Ding Y; Zhou Y; Li Z; Zhang H; Yang Y; Qin H; Xu Q; Zhao L
    Life Sci; 2020 Nov; 260():118411. PubMed ID: 32918978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulforaphane enhances temozolomide-induced apoptosis because of down-regulation of miR-21 via Wnt/β-catenin signaling in glioblastoma.
    Lan F; Pan Q; Yu H; Yue X
    J Neurochem; 2015 Sep; 134(5):811-8. PubMed ID: 25991372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TCTP promotes glioma cell proliferation in vitro and in vivo via enhanced β-catenin/TCF-4 transcription.
    Gu X; Yao L; Ma G; Cui L; Li Y; Liang W; Zhao B; Li K
    Neuro Oncol; 2014 Jan; 16(2):217-27. PubMed ID: 24311645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The long non-coding RNA, urothelial carcinoma associated 1, promotes cell growth, invasion, migration, and chemo-resistance in glioma through Wnt/β-catenin signaling pathway.
    Zhang B; Fang S; Cheng Y; Zhou C; Deng F
    Aging (Albany NY); 2019 Oct; 11(19):8239-8253. PubMed ID: 31596734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA MIR155HG Promotes Temozolomide Resistance by Activating the Wnt/β-Catenin Pathway Via Binding to PTBP1 in Glioma.
    He X; Sheng J; Yu W; Wang K; Zhu S; Liu Q
    Cell Mol Neurobiol; 2021 Aug; 41(6):1271-1284. PubMed ID: 32529543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TUG1 knockdown inhibits the tumorigenesis and progression of prostate cancer by regulating microRNA-496/Wnt/β-catenin pathway.
    Li G; Yang J; Chong T; Huang Y; Liu Y; Li H
    Anticancer Drugs; 2020 Jul; 31(6):592-600. PubMed ID: 32427740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.